A growing disease burden is changing the economics and direction of modern drug development. As cancer and chronic immune-related conditions become more widespread, healthcare systems are looking for therapies that can deliver more targeted responses. This shift is creating a powerful growth environment for the Immunotherapy Drugs Market, which reached USD 285.7 billion in 2025 and is expected...